Posts

Vaccines for Children: List By Age, Benefits, Safety

Image
Facebook Facebook Email or phone Password Forgot account? Create new account You're Temporarily Blocked You're Temporarily Blocked It looks like you were misusing this feature by going too fast. You've been temporarily blocked from using it. Back English (US) Español Français (France) 中文(简体) العربية Português (Brasil) Italiano 한국어 Deutsch हिन्दी 日本語 Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Voting Information Center Privacy Policy Consumer Health Privacy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Settings Activity log Meta © 2025 top care medical :: Article Creator

Meningococcal Vaccine: Protection, Risk, Schedule

Image
clozapine rems :: Article Creator FDA Eliminates Clozapine REMS Program Requirement The Food and Drug Administration (FDA) has removed the risk evaluation and mitigation strategies (REMS) program requirement for clozapine.  Clozapine, an atypical antipsychotic, is indicated for treatment-resistant schizophrenia and for reducing suicidal behavior in patients with schizophrenia or schizoaffective disorder. The Clozapine REMS program was established in 2015 due to the risk of severe neutropenia associated with the medication.   Prior to pharmacies dispensing clozapine, the FDA required patients to obtain and report a baseline absolute neutrophil count (ANC) blood test. In order to continue treatment, the ANC was to be monitored regularly.  In November 2024, the FDA held an in-person advisory committee meeting to reevaluate the clozapine REMS requirement. During this meeting, the committee voted 14 to 1 that the REMS requirement for ANC document...

Robert F. Kennedy Jr., Soon to Announce White House Run, Sows ...

Image
steroid clobetasol propionate :: Article Creator Clobetasol Propionate Clobetasol Propionate Generic Name & Formulations General Description Clobetasol propionate 0.05%; crm; oint; gel; soln for scalp application. How Supplied Contact supplier. Clobetasol Propionate Indications Indications Corticosteroid-responsive dermatoses. Clobetasol Propionate Dosage and Administration Adult Apply thin layer twice daily (AM & PM); max 50g/week or 50mL/week and 2 consecutive weeks' treatment per course. Children Not recommended. Clobetasol Propionate Contraindications Contraindications Do not use superpotent forms on face, groin, or axillae. Exclude viral disease (eg, chickenpox, measles). Clobetasol Propionate Boxed Warnings Not Applicable Clobetasol Propionate Warnings/Precautions Warnings/Precautions Treat infection if present; discontinue if infection persists or worsens. Do not use near ey...

Preventive Services Covered by Private Health Plans under the Affordable Care Act

Image
combination steroid and antifungal cream :: Article Creator

Robert F. Kennedy Jr., Soon to Announce White House Run, Sows ...

Image
over the counter local anesthetic :: Article Creator

Vaccines for Children: List By Age, Benefits, Safety

Image
anaphylaxis vaccine :: Article Creator

Examples of Outcome Reporting Bias in Vaccine Studies: Illustrating ...

Image
prn medication :: Article Creator Save The Date: Profound Medical To Host Investor Event At AUA 2025 TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will host a hybrid (in-person and virtual) investor event on Monday, April 28, 2025, during the American Urological Association's ("AUA") Annual Meeting in Las Vegas, NV, from 3:30 p.M. To 5:00 p.M. Pacific Time (6:30 p.M. To 8:00 p.M. Eastern Time). "The program will feature presentations from members of Profound's management team as well as by leading physicians on: (1) TULSA-PRO® and its unrivalled flexibility to treat a wide variety of prostate disease patients; (2) peri-operative results from the Level 1 CAPTAIN post-market study comparing th...